Elanchezhiyan Manickan
- Immunology top 5%
- Immunotherapy and Immune Responses 11
- Immune Response and Inflammation 4
- Virology top 5%
- Epidemiology top 5%
- Herpesvirus Infections and Treatments 10
- Hepatitis B Virus Studies 4
- Animal Science and Zoology top 5%
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology 2
-
- Virus-based gene therapy research 4
-
- Dermatology and Skin Diseases 3
-
- vaccines and immunoinformatics approaches 3
- Co-authors
- Barry T. RouseZhiya YuNelly A. KuklinKevin L. KaremRichard RouseWilliam S. WireMassoud DaheshiaSiva Kanangat
- Cited by
- ImmunologyVirologyEpidemiology
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)The Journal of Immunology (2 papers)
- Partner nations
- United StatesIndiaSaudi Arabia
In The Last Decade
Elanchezhiyan Manickan
26 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 72
- Immunology 746
- Virology 106
- Epidemiology 694
- Animal Science and Zoology 130
- Infectious Diseases 229
Countries citing papers authored by Elanchezhiyan Manickan
This map shows the geographic impact of Elanchezhiyan Manickan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elanchezhiyan Manickan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elanchezhiyan Manickan more than expected).
Fields of papers citing papers by Elanchezhiyan Manickan
This network shows the impact of papers produced by Elanchezhiyan Manickan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elanchezhiyan Manickan. The network helps show where Elanchezhiyan Manickan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elanchezhiyan Manickan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 0 | |
| 5 | Anti hepatitis B activity of methanolic extracts of Achyranthes aspera leaves | 2021 | 0 |
| 6 | 2020 | 7 | |
| 7 | 2019 | 12 | |
| 8 | 2017 | 7 | |
| 9 | 2012 | 7 | |
| 10 | 2005 | 107 | |
| 11 | 2001 | 31 | |
| 12 | 1998 | 19 | |
| 13 | 1998 | 26 | |
| 14 | 1998 | 43 | |
| 15 | 1998 | 9 | |
| 16 | 1997 | 92 | |
| 17 | 1997 | 81 | |
| 18 | 1997 | 105 | |
| 19 | 1997 | 179 | |
| 20 | 1995 | 51 |
About Elanchezhiyan Manickan
Elanchezhiyan Manickan is a scholar working on Immunology, Epidemiology and Virology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Herpesvirus Infections and Treatments (10 papers), Virus-based gene therapy research (4 papers), Immune Response and Inflammation (4 papers), Hepatitis B Virus Studies (4 papers), Dermatology and Skin Diseases (3 papers), vaccines and immunoinformatics approaches (3 papers) and Tuberculosis Research and Epidemiology (2 papers). The work is most often cited by research in Immunology (746 citations), Virology (106 citations) and Epidemiology (694 citations). Elanchezhiyan Manickan has collaborated with scholars based in United States, India and Saudi Arabia. Frequent co-authors include Barry T. Rouse, Zhiya Yu, Nelly A. Kuklin, Kevin L. Karem, Richard Rouse, William S. Wire, Massoud Daheshia, Siva Kanangat, Andrew P. Byrnes and Thomas L. Eggerman. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.